tissue microarray

NEW YORK (GenomeWeb News) – Nuclea Biotechnologies today announced the acquisition of a portfolio of six patents and applications related to tissue microarrays for an undisclosed amount.

Visiopharm and Integrated Systems Engineering have agreed to comarket their products to researchers using tissue microarrays.

By Justin Petrone
The National Institutes of Health is looking for a partner to commercialize a new tissue microarrayer that its inventor claims could cost one-tenth the price of similar instruments on the market.

The Karmanos Cancer Institute will use Definiens' Tissue Studio 2.0 digital pathology software to automate tissue section and microarray analysis.

Metamark disclosed last week in a filing with the US Securities and Exchange Commission that it raised about $22 million in a Series B round of financing. The company is targeting about $42 million in total.

Though many details have yet to be worked out, the draft deal for the UK's withdrawal from the EU is giving researchers some hints for what they can expect, Nature News says.

DNA testing has solved a 100-year-old mystery contained in the skull and teeth samples of a now-extinct monkey that once inhabited Jamaica, Gizmodo reports.

As the UN ponders a ban on gene drives, one malaria researcher says there are less dramatic ways to fight the disease in Africa than unleashing GM mosquitoes on a whole continent.

In Nature this week: an improved reference genome of the Aedes aegypti mosquito, genomes of four species of truffles, and more.